reports
TotalEnergies SE : Déclaration des Transactions sur Actions Propres
PARIS--(BUSINESS WIRE)-- Regulatory News: Dans le cadre de l’autorisation consentie par l’Assemblée générale ordinaire du 26 mai 2023 pour opérer sur ses actions et conformément à la réglementation relative aux rachats d'actions, TotalEnergies SE (LEI : 529900S21EQ1BO4ESM68) (Paris:TTE) (LSE:TTE) (NYSE:TTE) déclare ci-après les achats d’actions propres (FR0000120271) réalisés du 29 avril au 3 mai 2024 : Jour de la transaction Volume total journalier (en nombre de titres) Prix pondéré moyen journalier d'acquisition (en EUR/action) Montant des transactions (EUR) Cod...
EQS-News: Annual General Meeting of Hannover Rück SE approves dividend...
EQS-News: Hannover Rück SE / Key word(s): AGM/EGM Annual General Meeting of Hannover Rück SE approves dividend increase and appointment of new Supervisory Board members 06.05.2024 / 18:30 CET/CEST The issuer is solely responsible for the content of this announcement. Annual General Meeting of Hannover Rück SE approves dividend increase and appointment of new Supervisory Board members Total dividend of EUR 7.20 per share approved Chief Executive Officer Jean-Jacques Henchoz confident of further growing profitability over the strategy cycle 2024-2026 Hannover, 6 May 2024...
EQS-News: Hauptversammlung der Hannover Rück SE stimmt Dividendenerhöh...
EQS-News: Hannover Rück SE / Schlagwort(e): Hauptversammlung Hauptversammlung der Hannover Rück SE stimmt Dividendenerhöhung und Bestellung neuer Aufsichtsratsmitglieder zu 06.05.2024 / 18:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Hauptversammlung der Hannover Rück SE stimmt Dividendenerhöhung und Bestellung neuer Aufsichtsratsmitglieder zu Gesamt-Dividende von 7,20 EUR je Aktie beschlossen Vorstandsvorsitzender Jean-Jacques Henchoz zuversichtlich für den weiteren Ausbau der Profitabilität im Strategiezyklus 2024-2026 Hanno...
Repurchase of Shares
Repurchase of Shares Repurchase of Shares Amsterdam, the Netherlands - Flow Traders Ltd. (Euronext: FLOW) has repurchased 46,070 of its own shares in the period from 29 April 2024 up to and including 3 May 2024 at an average price of €19.57. This is in accordance with the €15 million share buyback extension program originally announced on 27 October 2022, of which the period of execution was announced on 28 July 2023 to be extended by 12 months to 26 October 2024. The consideration of this purchase was €0.9 million. The total number of shares purchased under this program to date is 51...
Novo Nordisk AS: 1 director
A director at Novo Nordisk AS sold 55,000 shares at 902.625DKK and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
GSK: 1 director
A director at GSK sold 6,000 shares at 1,702p and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close p...
RUBIS: Information relating to the total number of voting rights and s...
RUBIS: Information relating to the total number of voting rights and shares as of 30/04/2024 Paris, 3 May 2024, 5:45 pm INFORMATION ON TOTAL NUMBER OF VOTING RIGHTS AND NUMBER OF SHARES PURSUANT TO ARTICLE L.233-8 II OF THE FRENCH COMMERCIAL CODE AND ARTICLE 223-16 OF THE GENERAL REGULATION OF THE FRENCH FINANCIAL MARKETS AUTHORITY DateClass of sharesNumber of sharesNumber of theoretical voting rightsNumber of exercisable voting rights (excluding shares bought back by the Company*)30 April 2024Ordinary shares (par value of €1,25)103,596,246103,596,246103,556,575 * Shares bought back by...
RUBIS: Déclaration de capital et de droits de vote au 30/04/2024
RUBIS: Déclaration de capital et de droits de vote au 30/04/2024 Paris, le 3 mai 2024, 17h45 INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS PRÉVUES PAR L’ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L’ARTICLE 223-16 DU RÈGLEMENT GÉNÉRAL DE L’AUTORITÉ DES MARCHÉS FINANCIERS Date Catégorie d’actions Nombre d’actions Nombre de droits de vote théoriques Nombre de droits de vote exerçables(hors actions autodétenues*) 30 avril 2024 Actions ordinaires (1,25 € de nominal) 103 596 246 103 596 246 103 556 575 * ** Les actions autodétenues son...
RUBIS: 11 June 2024 Ordinary Shareholders' Meeting - Availability of t...
RUBIS: 11 June 2024 Ordinary Shareholders' Meeting - Availability of the preparatory documents Paris, 3 May 2024, 17:40 pm The Rubis shareholders are invited to attend the Ordinary Shareholders’ Meeting that will take place on: Tuesday 11 June 2024 at 2:00 pmat Eurosites Salle Wagram- 39, avenue de Wagram - 75017 Paris The agenda, the resolutions and the ways of attending and voting at this Shareholders’ Meeting are set out in the notice of meeting (Avis de réunion) published in the Bulletin des Annonces Légales Obligatoires (“BALO”) on 3 May 2024. It is also availa...
RUBIS: Assemblée Générale Ordinaire du 11 juin 2024 - Modalités de mis...
RUBIS: Assemblée Générale Ordinaire du 11 juin 2024 - Modalités de mise à disposition des documents préparatoires Paris, le 3 mai 2024, 17h40 Les actionnaires de Rubis sont invités à participer à l’Assemblée Générale Ordinaire qui se tiendra le : Mardi 11 juin 2024 à 14 heuresà Eurosites Salle Wagram- 39, avenue de Wagram - 75017 Paris L’ordre du jour, le projet de résolutions ainsi que les modalités de participation et de vote à l’Assemblée sont détaillés dans l’avis de réunion publié au Bulletin des Annonces Légales Obligatoires (Balo) du 3 mai 2024 qui est égalemen...
TotalEnergies : Assemblée générale ordinaire et extraordinaire du 24 m...
PARIS--(BUSINESS WIRE)-- Regulatory News: Les actionnaires de la Société sont invités à participer à l’Assemblée générale ordinaire et extraordinaire de TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) qui se tiendra vendredi 24 mai 2024, à 14 heures, à la Tour Coupole, 2 place Jean Millier, La Défense 6, 92 400 Courbevoie. L’Assemblée générale sera retransmise en direct en intégralité sur le site internet . Toutes les informations utiles relatives à cette Assemblée sont régulièrement mises à jour sur cette page du site. Les actionnaires peuvent exercer leur droit de vote préalablement ...
- Jerôme Bodin
ODDO BHF Small & MIDCAP MORNING NEWS - 03/05/2024
Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to 2026e...
- Jerôme Bodin
ODDO BHF Small & MIDCAP MORNING NEWS - 05/03/2024
Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to 2026e...
- Stephane Foucaud
AUCTUS ON FRIDAY - 03/05/2024
AUCTUS PUBLICATIONS ________________________________________ ADX Energy (ADX AU)C; target price of A$0.75 per share: Raising new equity to fund a high impact activity programme – ADX has raised A$13.5 mm of new equity priced at A$0.105 per share. One free-attaching option will be issued for evert two placement shares with an exercise price of A$0.15 per share and an expiry date of 08/05/2026. The proceeds from the raise will fund (1) the production testing of the 450 m gas column encountered at ...
GALP GALP ENERGIA SGPS SA CLASS B
GTE GRAN TIERRA ENERGY
EGY VAALCO ENERGY INC.
OMV OMV AG
TXP TOUCHSTONE EXPLORATION
SEI. SINTANA ENERGY
CHAR CHARIOT OIL & GAS
PEN PANORO ENERGY ASA
DELT DELTIC ENERGY
CNE CANACOL ENERGY LTD
ZPHR ZEPHYR ENERGY
JSE JADESTONE ENERGY
AXL. ARROW EXPLORATION LTD
I3E I3 ENERGY
TRIN TRINITY CAPITAL INC
CEQ CRITERIUM ENERGY LTD.
ADX ADX ENERGY LTD
BWEFF BW ENERGY LTD
LNGE LNG ENERGY GROUP CORP.
SHELL ROYAL DUTCH SHELL
- Dominic Rose
- Naresh Chouhan
Sanofi - The Path to €120 (BUY, TP EUR120 [110], 7pgs)
This new analysis shows how Sanofi shares get to €120 (+c.30%) by end 2025. We have conducted a foundational analysis that investors can refer to over the next 18mths as Sanofi releases at least 15 P2 & P3 pipeline readouts. We show the upside potential from every single readout and show that just 4 drugs could add €18/share upon successful readouts. In addition to multiple readouts, the likely Consumer Health spin in Q4, the tolebrutinib overhang being resolved one way or another and a strong C...
- Louis Boujard
- CFA
- Philippe Ourpatian
Neoen : Q1 2024 revenue in line, guidance confirmed and still question...
>Outperform rating and target price of € 35.50 unchanged - The Q1 2024 revenue release was fully in line with our expectations (€ 141.4m vs € 144.9m estimated). The group also confirmed its 2024 guidance and that for 2030. We maintain our Outperform rating and target price of € 35.5 still based on the average of a sum-of-the-parts (€ 35.4) and a DCF (€ 35.6 and unchanged growth to infinity of 1.80%). The current market capitalisation points to a certain upside from b...
- Louis Boujard
- CFA
- Philippe Ourpatian
Neoen : CA T1 24 en ligne, guidances confirmées et toujours des questi...
>Opinion Surperformance et OC 35.50 € inchangés - La publication du chiffre d’affaires du T1 24 est ressortie parfaitement en ligne avec nos anticipations (141.4 M€ vs 144.9 M€ estimés). Le groupe confirme également ses guidances 2024 ainsi que celles de 2030. Nous maintenons notre recommandation Surperformance et notre objectif de cours de 35.5 € toujours fondé sur une moyenne entre une somme des parties (35.4 €) et un DCF (35.6 € et taux de croissance à l’infini in...
- Rune Majlund Dahl
Novo Nordisk (Buy, TP: DKK1100.00) - Small guidance raise
Q1 LCY figures beat consensus due to US rebate adjustments related to 2023 adding c5%-points to LCY growth and low SG&A cost boosting EBIT growth in Q1. Wegovy sales were below consensus but above our forecast, and we have therefore adjusted our rebate assumptions for 2024. The 2024 guidance was raised to LCY sales growth of 19–27% (18–26%) and LCY operating profit growth of 22–30% (21–29%). We reiterate our BUY and DKK1,100 target price.
- Carole Braudeau
- Jean Danjou
- Oliver Metzger
- Thomas Zlowodzki
A1XEH4 CROSSJECT SA
TFI TELEVISION FRANCAISE 1 SA
ISS ISS A/S
NRG NRJ GROUP SA
ALTA ALTAREA SCA
BOSS HUGO BOSS AG
G24 SCOUT24 AG
BAMNB KONINKLIJKE BAM GROEP NV
GLB GLANBIA PLC
SAVE SAVENCIA SA
FIE FIELMANN AG
VID VIDRALA SA
VLK VAN LANSCHOT KEMPEN NV CERT. OF SHS
AED AEDIFICA SA
BEZ BERENTZEN GRUPPE
WAF SILTRONIC AG
TWEKA TKH GROUP N.V. CERT
OREGE OREGE SA
LNSX SIXT LEASING AG
FFARM FORFARMERS
MVC METROVACESA SA
VOS VOSSLOH AG
NEOEN NEOEN S.A.
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
TE TECHNIP ENERGIES NV
C3RY CHERRY AG
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.